BioMarin’s dwarfism drug Voxzogo could be its next blockbuster, but ethics questions loom over the launch

BioMarin’s dwarfism drug Voxzogo could be its next blockbuster, but ethics questions loom over the launch
esagonowsky
Fri, 11/19/2021 – 11:18